| P2093 | author name string | Robert Knobler | |
| | Carla Oliveira-Ribeiro | |
| | Karla Strong Rodrigues | |
| | Silvia de Abreu Fiuza Gomes | |
| P2860 | cites work | Hyperacute GVHD: risk factors, outcomes, and clinical implications | Q79397230 |
| | Acquired ichthyosis as a manifestation of acute cutaneous graft-versus-host disease | Q79774723 |
| | A single-center pilot validation study of a new chronic GVHD skin scoring system | Q80390089 |
| | Normal-looking skin in oncohaematological patients after allogenic bone marrow transplantation is not normal | Q80585680 |
| | Anti-tumor necrosis factor-a for the treatment of steroid-refractory acute graft-versus-host disease | Q80830121 |
| | Chronic graft-versus-host disease with skin signs suggestive of dermatomyositis | Q81534118 |
| | The effect of intensified extracorporeal photochemotherapy on long-term survival in patients with severe acute graft-versus-host disease | Q82795562 |
| | Spontaneous graft versus host disease occurring in a patient with multiple myeloma after autologous stem cell transplant | Q83096697 |
| | Chronic cutaneous graft-versus-host disease simulating hypertrophic lupus erythematosus--a case report of a new morphologic variant of graft-versus-host disease | Q83393784 |
| | Graft-versus-host disease: part I. Pathogenesis and clinical manifestations of graft-versus-host disease | Q83661208 |
| | Diagnosis and management of acute graft-versus-host disease | Q83992372 |
| | First-in-man clinical results of the treatment of patients with graft versus host disease with human ex vivo expanded CD4+CD25+CD127- T regulatory cells | Q84135263 |
| | Isomorphic cutaneous graft-versus-host disease reaction after ultraviolet exposure: clinical, histological and direct immunofluorescence studies of four allo-transplanted patients | Q84195658 |
| | Progressive improvement in cutaneous and extracutaneous chronic graft-versus-host disease after a 24-week course of extracorporeal photopheresis--results of a crossover randomized study | Q84215346 |
| | Quantitative analysis of eosinophils in acute graft-versus-host disease compared with drug hypersensitivity reactions | Q84513679 |
| | Eosinophilic fasciitis following allogeneic bone marrow transplantation in a patient with acute myeloid leukaemia | Q85197845 |
| | Narrowband ultraviolet B phototherapy ameliorates acute graft-versus-host disease by a mechanism involving in vivo expansion of CD4+CD25+Foxp3+ regulatory T cells | Q87335552 |
| | Activity of therapeutic JAK 1/2 blockade in graft-versus-host disease | Q87635679 |
| | Randomized double-blind clinical trial comparing clobetasol and dexamethasone for the topical treatment of symptomatic oral chronic graft-versus-host disease | Q87671181 |
| | [Epidermolysa bullosa acquisita and graft-versus-host disease] | Q87892647 |
| | Atypical manifestations of graft-versus-host disease. | Q53629025 |
| | The development of autoantibodies after allogeneic stem cell transplantation is related with chronic graft-vs-host disease and immune recovery. | Q53632072 |
| | Sclerodermatous chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation: incidence, predictors and outcome. | Q53637756 |
| | A Pediatric Case of Sclerodermatous Graft-Versus-Host Disease Responsive to Ultraviolet A1 Phototherapy. | Q53797605 |
| | Regulatory T Cells in Chronic Graft-Versus-Host Disease After Extracorporeal Photopheresis: Correlation With Skin and Global Organ Responses, and Ability to Taper Steroids. | Q54096026 |
| | UVA (UVA-1) therapy for the treatment of acute GVHD of the skin | Q57515085 |
| | Ocular Manifestation of Acute Graft-Versus-Host Disease After Allogeneic Peripheral Blood Stem Cell Transplantation | Q57919072 |
| | Multiparity induces priming to male-specific minor histocompatibility antigen, HY, in mice and humans | Q61657706 |
| | Identification and validation of biomarkers associated with acute and chronic graft versus host disease | Q61740052 |
| | Tratamiento de rescate con infliximab de la enfermedad del injerto contra el huésped resistente a glucocorticoides | Q62607770 |
| | Sclerodermatous chronic graft-versus-host disease. Analysis of seven cases | Q67733168 |
| | Acute follicular graft-vs-host reaction. A distinct clinicopathologic presentation | Q68136604 |
| | Risk factors for chronic graft-versus-host disease after HLA-identical sibling bone marrow transplantation | Q68809214 |
| | Female marrow donors increase the risk of acute graft-versus-host disease: effect of donor age and parity and analysis of cell subpopulations in the donor marrow inoculum | Q68882655 |
| | Increased serum levels of tumor necrosis factor alpha precede major complications of bone marrow transplantation | Q68928908 |
| | Histopathology of graft-vs.-host reaction (GvHR) in human recipients of marrow from HL-A-matched sibling donors | Q70055061 |
| | Predictive Factors in Chronic Graft-Versus-Host Disease in Patients with Aplastic Anemia Treated by Marrow Transplantation from HLA-Identical Siblings | Q70249255 |
| | [Graft versus host disease after transfusion of blood and its products] | Q70420262 |
| | Evidence for a graft-versus-tumor effect in a patient treated with marrow ablative chemotherapy and allogeneic bone marrow transplantation for breast cancer | Q71228966 |
| | Chronic sclerodermic graft-versus-host disease refractory to immunosuppressive treatment responds to UVA1 phototherapy | Q73294447 |
| | Clearance of apoptotic cells: TGF-beta in the balance between inflammation and fibrosis | Q73910583 |
| | Soluble interleukin-2 receptor concentration as a biochemical indicator for acute graft-versus-host disease after allogeneic bone marrow transplantation | Q73998866 |
| | Cutaneous graft-versus-host disease | Q74599444 |
| | Diverse T-cell responses characterize the different manifestations of cutaneous graft-versus-host disease | Q42239977 |
| | Ruxolitinib in steroid refractory graft-vs.-host disease: a case report | Q42255208 |
| | Mycophenolate mofetil use after unrelated hematopoietic stem cell transplantation for prophylaxis and treatment of graft-vs.-host disease in adult patients in Japan | Q43522314 |
| | Tacrolimus ointment in the treatment of chronic cutaneous graft-vs-host disease: a case series of 18 patients | Q43739276 |
| | Early antithymocyte globulin therapy improves survival in patients with steroid-resistant acute graft-versus-host disease | Q43891093 |
| | Response of 443 patients to steroids as primary therapy for acute graft-versus-host disease: comparison of grading systems | Q44097093 |
| | Mycophenolate mofetil for the treatment of acute and chronic GVHD is effective and well tolerated but induces a high risk of infectious complications: a series of 21 BM or PBSC transplant patients | Q44123964 |
| | Chronic graft-versus-host-disease involving the oral mucosa: clinical presentation and treatment | Q44193082 |
| | Topical tacrolimus--a novel treatment alternative for cutaneous chronic graft-versus-host disease | Q44454940 |
| | Treatment of moderate/severe acute graft-versus-host disease after allogeneic bone marrow transplantation: an analysis of clinical risk features and outcome | Q44521800 |
| | A multicenter prospective phase 2 randomized study of extracorporeal photopheresis for treatment of chronic graft-versus-host disease | Q44528839 |
| | Pustular acral erythema in a patient with acute graft-versus-host disease | Q44563447 |
| | Treatment of extensive chronic cutaneous graft-versus-host disease in an infant with topical pimecrolimus | Q44903591 |
| | Lack of association of platelet-derived growth factor (PDGF) receptor autoantibodies and severity of chronic graft-versus-host disease (GvHD). | Q45243246 |
| | Successful treatment using tacrolimus ointment for cutaneous graft-versus-host disease | Q46252266 |
| | Sirolimus in combination with tacrolimus and corticosteroids for the treatment of resistant chronic graft-versus-host disease | Q46617730 |
| | Infliximab for steroid refractory or dependent gastrointestinal acute graft-versus-host disease in children after allogeneic hematopoietic stem cell transplantation. | Q47244516 |
| | Clinicopathologic characteristics of cutaneous chronic graft-versus-host diseases: a retrospective study in Korean patients. | Q51528412 |
| | Loss of normal thymic repertoire selection and persistence of autoreactive T cells in graft vs host disease. | Q52511889 |
| | Mycophenolate mofetil is effective only for involved skin in the treatment for steroid-refractory acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation. | Q52842045 |
| | Characterization of oral involvement in acute graft-versus-host disease. | Q53038031 |
| | Evidence of Th1, Th17 and Tc17 cells in psoriasiform chronic graft-versus-host disease. | Q53355195 |
| | A case of acute cutaneous graft-versus-host disease mimicking psoriasis vulgaris. | Q53514797 |
| | Ancillary therapy and supportive care of chronic graft-versus-host disease: national institutes of health consensus development project on criteria for clinical trials in chronic Graft-versus-host disease: V. Ancillary Therapy and Supportive Care Wo | Q36424524 |
| | A Randomized Phase II Crossover Study of Imatinib or Rituximab for Cutaneous Sclerosis after Hematopoietic Cell Transplantation | Q36471247 |
| | Chronic Graft-Versus-Host Disease Mimicking Psoriasis in a Patient with Hemophagocytic Lymphohistiocytosis. | Q36534619 |
| | More immune dysregulation: Sarcoidosis and chronic graft-versus-host disease after allogeneic stem cell transplant | Q36735696 |
| | National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: V. The 2014 Ancillary Therapy and Supportive Care Working Group Report | Q36766324 |
| | Narrowband ultraviolet B phototherapy for the treatment of steroid-refractory and steroid-dependent acute graft-versus-host disease of the skin | Q36841859 |
| | Ruxolitinib in corticosteroid-refractory graft-versus-host disease after allogeneic stem cell transplantation: a multicenter survey | Q36862931 |
| | T-cell receptor Valpha spectratype analysis of a CD4-mediated T-cell response against minor histocompatibility antigens involved in severe graft-versus-host disease | Q37014964 |
| | High frequency of cutaneous manifestations including vitiligo and alopecia areata in a prospective cohort of patients with chronic graft-vs-host disease | Q37075979 |
| | Dermoscopic Follow-Up of the Skin towards Acute Graft-versus-Host-Disease in Patients after Allogeneic Hematopoietic Stem Cell Transplantation | Q37092833 |
| | Thymic damage, impaired negative selection, and development of chronic graft-versus-host disease caused by donor CD4+ and CD8+ T cells | Q37104254 |
| | Initial therapy of acute graft-versus-host disease with low-dose prednisone does not compromise patient outcomes | Q37143633 |
| | Steroids Versus Steroids Plus Additional Agent in Frontline Treatment of Acute Graft-versus-Host Disease: A Systematic Review and Meta-Analysis of Randomized Trials | Q37302887 |
| | Acute graft-versus-host disease: are we close to bringing the bench to the bedside? | Q37402799 |
| | Ibrutinib efficacy and tolerability in patients with relapsed chronic lymphocytic leukemia following allogeneic HCT. | Q37528067 |
| | A combined biomarker and clinical panel for chronic graft versus host disease diagnosis | Q37601730 |
| | An early-biomarker algorithm predicts lethal graft-versus-host disease and survival. | Q37624364 |
| | Reversal of CD8 T-cell-mediated mucocutaneous graft-versus-host-like disease by the JAK inhibitor tofacitinib | Q37652919 |
| | German-Austrian-Swiss Consensus Conference on clinical practice in chronic graft-versus-host disease (GVHD): guidance for supportive therapy of chronic cutaneous and musculoskeletal GVHD. | Q37861866 |
| | Danger signals activating innate immunity in graft-versus-host disease | Q37875779 |
| | Clinical differentiation of acute cutaneous graft-versus-host disease from drug hypersensitivity reactions | Q37884977 |
| | Acute graft-versus-host disease following hematopoietic stem-cell transplantation | Q37930715 |
| | Graft-versus-host disease: part II. Management of cutaneous graft-versus-host disease | Q37993979 |
| | Biology of graft-versus-host responses: recent insights | Q38071746 |
| | Consensus on performing skin biopsies, laboratory workup, evaluation of tissue samples and reporting of the results in patients with suspected cutaneous graft-versus-host disease | Q38255272 |
| | Phototherapy for the treatment of cutaneous graft versus host disease. | Q38258802 |
| | The role of phototherapy in cutaneous chronic graft-vs-host disease: a retrospective study and review of the literature | Q38511678 |
| | Graft Versus Host Disease After Liver Transplantation in Adults: A Case series, Review of Literature, and an Approach to Management | Q38919897 |
| | Chronic graft-versus-host disease: biological insights from preclinical and clinical studies | Q39002164 |
| | The effect of neonatal rat graft-vs-host disease (GVHD) on Fc receptor lymphocytes | Q39068494 |
| | Narrow-band UVB phototherapy for management of oral chronic graft-versus-host disease | Q39127779 |
| | Toxic tacrolimus levels after application of topical tacrolimus and use of occlusive dressings in two bone marrow transplant recipients with cutaneous graft-versus-host disease | Q39209040 |
| | 1994 Consensus Conference on Acute GVHD Grading | Q39513397 |
| | Mycophenolate mofetil for treatment of steroid-refractory acute graft-versus-host disease after pediatric hematopoietic stem cell transplantation | Q41144188 |
| | Clinical significance of autoantibodies in a large cohort of patients with chronic graft-versus-host disease defined by NIH criteria | Q41180891 |
| | Acute cutaneous graft-versus-host disease resembling type II (atypical adult) pityriasis rubra pilaris | Q41420527 |
| | Response-guided therapy for steroid-refractory acute GVHD starting with very-low-dose antithymocyte globulin | Q41547054 |
| | Corticosteroid-Free Primary Treatment of Chronic Extensive Graft-versus-Host Disease Incorporating Rituximab | Q41731246 |
| | Donor-derived mycosis fungoides following reduced intensity haematopoietic stem cell transplantation from a matched unrelated donor. | Q42087799 |
| | Elafin is a biomarker of graft-versus-host disease of the skin | Q24622918 |
| | NIH Consensus development project on criteria for clinical trials in chronic graft-versus-host disease: II. The 2014 Pathology Working Group Report | Q28081289 |
| | First-line therapy for chronic graft-versus-host disease that includes low-dose methotrexate is associated with a high response rate | Q33383699 |
| | Consensus conference on clinical practice in chronic graft-versus-host disease (GVHD): first-line and topical treatment of chronic GVHD. | Q33624804 |
| | Many faces of graft-versus-host disease | Q34098192 |
| | High levels of B-cell activating factor in patients with active chronic graft-versus-host disease | Q34135089 |
| | Infusion of ex vivo expanded T regulatory cells in adults transplanted with umbilical cord blood: safety profile and detection kinetics | Q34144161 |
| | Graft-versus-host disease after nonmyeloablative versus conventional hematopoietic stem cell transplantation | Q34186689 |
| | Graft-versus-host disease-associated angiomatosis: a clinicopathologically distinct entity | Q34195672 |
| | Organ-specific management and supportive care in chronic graft-versus-host disease | Q34270868 |
| | Acute and chronic graft-versus-host disease after allogeneic peripheral-blood stem-cell and bone marrow transplantation: a meta-analysis | Q34337007 |
| | National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report | Q34474243 |
| | Sclerodermatous graft-vs-host disease: clinical and pathological study of 17 patients | Q34692953 |
| | Guidelines on the use of extracorporeal photopheresis | Q34918643 |
| | How we treat chronic graft-versus-host disease | Q35004923 |
| | Histone deacetylase inhibition regulates inflammation and enhances Tregs after allogeneic hematopoietic cell transplantation in humans | Q35029450 |
| | The pathophysiology of chronic graft-versus-host disease: the unveiling of an enigma | Q35084404 |
| | National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group report | Q35085226 |
| | A prognostic score for acute graft-versus-host disease based on biomarkers: a multicentre study | Q35120338 |
| | Ibrutinib treatment ameliorates murine chronic graft-versus-host disease | Q35140097 |
| | Sclerotic-type chronic GVHD of the skin: clinical risk factors, laboratory markers, and burden of disease | Q35483838 |
| | Prevention of GVHD while sparing GVL effect by targeting Th1 and Th17 transcription factor T-bet and RORγt in mice | Q35525708 |
| | Imatinib mesylate for the treatment of steroid-refractory sclerotic-type cutaneous chronic graft-versus-host disease | Q35588726 |
| | Risk factors for acute GVHD and survival after hematopoietic cell transplantation | Q35651735 |
| | Humanized anti-CD25 monoclonal antibody treatment of steroid-refractory acute graft-versus-host disease: a Chinese single-center experience in a group of 64 patients | Q35669073 |
| | Inhibition of BTK and ITK with Ibrutinib Is Effective in the Prevention of Chronic Graft-versus-Host Disease in Mice | Q35766798 |
| | Reduced frequency of FOXP3+ CD4+CD25+ regulatory T cells in patients with chronic graft-versus-host disease | Q35848361 |
| | Rituximab for steroid-refractory chronic graft-versus-host disease | Q35848933 |
| | Fibrotic disease and the T(H)1/T(H)2 paradigm | Q35852270 |
| | Therapeutic targeting of IL-4- and IL-13-responsive cells in pulmonary fibrosis | Q35942450 |
| | CD8+ Foxp3+ regulatory T cells are induced during graft-versus-host disease and mitigate disease severity | Q36055096 |
| P275 | copyright license | Creative Commons Attribution-NonCommercial | Q6936496 |
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | skin disease | Q949302 |
| | hematopoietic stem cell transplantation | Q1128050 |
| | graft-versus-host disease | Q1194520 |
| | biomedical investigative technique | Q66648976 |
| P5008 | on focus list of Wikimedia project | ScienceSource | Q55439927 |
| P304 | page(s) | 33-50 | |
| P577 | publication date | 2017-06-27 | |
| | 2018-02-01 | |
| P1433 | published in | American Journal of Clinical Dermatology | Q18616212 |
| P1476 | title | Cutaneous Graft-Versus-Host Disease: Diagnosis and Treatment | |
| P478 | volume | 19 | |